Zika: Response funding
imprimir
WHO/PAHO and partners have set out a strategic response to Zika that focuses on preventing and managing medical complications caused by Zika virus infection. To date, US$122.1 million are necessary to effectively implement the Zika Strategic Response Plan, July 2016 to December 2017.
Contingency Fund for Emergencies background
5 reasons to support WHO’s global response to Zika virus
- WHO is the only agency with universal legitimacy in matters of international health, to lead and coordinate the response to Zika.
- WHO helps countries develop and strengthen health and social services for individuals, families and communities affected by Zika.
- WHO fast-tracks the availability of effective diagnostic tests, vaccines and public health guidance.
- WHO works with countries to prevent adverse health outcomes through mosquito control, risk communication and community engagement.
- WHO communicates vital information to decision-makers.
Zika virus and its complications, such as microcephaly and Guillain-Barré syndrome, represent a new type of public health threat with long-term consequences for families, communities and countries. As the Zika response moves from an acute emergency setting to a longer-term programmatic approach, funding must also transition to longer-term national and international development and technical assistance programmes.
Between February and July 2016 WHO/PAHO received 14.2 US$ million in direct contributions from 11 donors. This support has been pivotal in enabling a rapid and effective response. Immediate priority areas for funding from July 2016 to December 2017 include preventing and managing the medical complications caused by Zika virus infection, expanding health systems’ capacities, sexual and reproductive health, risk communication targeting pregnant women, and integrated vector management.